Enteral glutamine: A novel mediator of PPARγ in the postischemic gut

Journal of Leukocyte Biology

Volumn 84, Issue 3, 2008, Pages 595-599

  Ban, Kechen ^a   Kozar, Rosemary A ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Arginine; Gut ischemia reperfusion; IEC 6 cells; Peroxisome proliferator response element

Indexed keywords

ADENOSINE TRIPHOSPHATE; CELL NUCLEUS RECEPTOR; GLUTAMINE; NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADIPOCYTE; CRITICALLY ILL PATIENT; ENTERIC FEEDING; ENTERITIS; GLUCOSE HOMEOSTASIS; HUMAN; INTESTINE ISCHEMIA; INTESTINE PERFUSION; METABOLIC STRESS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ENTERAL NUTRITION; GLUTAMINE; HUMANS; INTESTINE, SMALL; ISCHEMIA; PPAR GAMMA; REPERFUSION INJURY;

RODENTIA;

EID: 50849136855     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1107764     Document Type: Review

References (42)

1. Cryer, H. G., Leong, K., McArthur, D. L., Demetriades, D., Bongard, F. S., Fleming, A. W., Hiatt, J. R., Kraus, J. F. (1999) Multiple organ failure: by the time you predict it, it's already there. J. Trauma 46, 597-606.
2. Kudsk, K. A., Minared, G., Croce, M. A. (1996) A randomized trial of isonitrogenous diets following severe trauma: an immune-enhancing diet reduces septic complications. Ann. Surg. 224, 531-543.
3. Daly, J. M., Lieberman, M. D., Goldfine, J., Shou, J., Weintraub, F., Rosato, E. F., Lavin, P. (1992) Enteral nutrition with supplemental arginine, RNA, and omega-3 fatty acids in patients after operation: immunologic, metabolic, and clinical outcome. Surgery 112, 56-67.
4. Heyland, D. K., Novak, F., Drover, J. W., Jain, M., Su, X., Suchner, U. (2001) Should immunonutrition become routine in the critically ill patient? JAMA 286, 944-953.
5. Bertolini, G., Iapichino, G., Radrizzani, D., Facchini, R., Simini, B., Bruzzone, P., Zanforlin, G., Tognoni, G. (2003) Early enteral immunonutrition in patients with severe sepsis: results of an interim analysis of a randomized multicentre clinical trial. Intensive Care Med. 29, 834-840.
6. Heyland, D. K., Samis, A. (2003) Does immunonutrition in patients with sepsis do more harm than good? Intensive Care Med. 29, 669-671.
7. Novak, F., Heyland, D. K., Avenell, A., Drover, J. W., Su, X. (2002) Glutamine supplementation in serious illness: a systematic review of the evidence. Crit. Care Med. 30, 2022-2029.
8. Houdijk, A. P. J., Rijnsburger, E. R., Jansen, J., Wesdorp, R. I. C., Weiss, J. K., McCamish, M. A., Teerlink, T., Meuwissen, S. G. M., Haarman, H. J., Thijs, L. G., Van Leeuwen, P. A. M. (1998) Randomized trial of glutamine-enriched enteral nutrition on infectious morbidity in patients with multiple trauma. Lancet 352, 772-776.
9. Garrel, D., Patenaude, J., Nedelec, B., Samson, L., Dorais, J., Champoux, J., D'Elia, M., Bernier, J. (2003) Decreased mortality and infectious morbidity in adult burn patients given enteral glutamine supplements: a prospective, controlled, randomized clinical trial. Crit. Care Med. 31, 2444-2449.
10. Zhou, Y., Jiang, Z., Sun, Y., Wang, X., Ma, E., Wilmore, D. (2003) The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trail. JPEN. J. Parenter. Enteral. Nutr. 27, 241-245.
11. Conejero, R., Bonet, A., Grau, T., Esteban, A., Mesejo, A., Montejo, J. C., Lopez, J., Acosta, J. A. (2002) Effect of a glutamine-enriched enteral diet on intestinal permeability and infectious morbidity at 28 days in critically ill patients with systemic inflammatory response syndrome: a randomized, single-blind, prospective, multicenter study. Nutrition 18, 716-721.
12. De-Souza, D. A., Greene, L. J. (2005) Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit. Care Med. 33, 1125-1135.
13. Gaddy, M. C., Max, M. H., Schwab, C. W., Kauder, K. (1986) Small bowel ischemia: a consequence of feeding jejunostomy. South. Med. J. 79, 180-182.
14. Schunn, C. D. G., Daly, J. M. (1995) Small bowel necrosis associated with postoperative jejunal tube feeds. J. Am. Coll. Surg. 180, 410-416.
15. Munshi, I. A., Steingrub, J. S., Wolpert, L. (2000) Small bowel necrosis associated with early postoperative tube feeding in a trauma patient. J. Trauma 49, 163-165.
16. Marvin, R. G., McKinley, B. A., McQuigan, M., Cocanour, C. S., Moore, F. A. (2000) Nonocclusive bowel necrosis occurring in critically ill trauma patients receiving enteral nutrition manifests no reliable clinical signs for early detection. Am. J. Surg. 179, 7-12.
17. Smith-Choban, P., Max, M. H. (1988) Feeding jejunostomy: a small bowel stress test? Am. J. Surg. 155, 112-117.
18. Kozar, R. A., Schultz, S. G., Hassoun, H. T., DeSoignie, R., Weisbrodt, N. W., Haber, M. M., Moore, F. A. (2002) The type of sodium-coupled solute modulates small bowel mucosal injury, transport function, and ATP after ischemia/reperfusion injury in rats. Gastroenterology 123, 810-816.
19. Kozar, R. A., Hu, S., Hassoun, H. T., DeSoignie, R., Moore, F. A. (2002) Specific intraluminal nutrients alter mucosal blood flow during gut ischemia/ reperfusion. JPEN. J. Parenter. Enteral. Nutr. 26, 226-229.
20. Flynn, W. J., Gosche, J. R., Garrison, N. R. (1992) Intestinal blood flow is restored with glutamine or glucose suffusion after hemorrhage. J. Surg. Res. 52, 499-504.
21. Matheson, P. J., Spain, D. A., Harris, P. D., Garrison, R. N., Wilson, M. A. (1999) Glucose and glutamine gavage increase portal vein nitric oxide metabolite levels via adenosine A2b activation. J. Surg. Res. 84, 57-63.
22. Kozar, R. A., Schultz, S. G., Bick, R. J., Poindexter, B. J., DeSoignie, R., Moore, F. A. (2004) Enteral glutamine but not alanine maintains small bowel barrier function after ischemia/reperfusion injury in rats. Shock 21, 433-437.
23. Kozar, R. A., Verner-Cole, E., Schultz, S., Sato, N., Bick, R. J., Desoignie, R., Poindexter, B. J., Moore, F. A. (2004) The immune-enhancing enteral agents arginine and glutamine differentially modulate gut barrier function following mesenteric ischemia/reperfusion. J. Trauma 57, 1150-1156.
24. Sato, N., Moore, F., Smith, M. A., Zou, L., Olufemi-Moore, S., Schultz, S. G., Kozar, R. A. (2006) Differential induction of PPAR{γ} by luminal glutamine and iNOS by luminal arginine in the rodent post ischemic small bowel. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G616-G623.
25. Wischmeyer, P. E. (2006) Glutamine: the first clinically relevant pharmacological regulator of heat shock protein expression? Curr. Opin. Clin. Nutr. Metab. Care 9, 201-206.
26. McQuiggan, M., Kozar, R. A., McKinley, B. A., Sailors, R. M., Moore, F. A. (2008) Enteral glutamine during active shock resuscitation is safe and enhances tolerance. JPEN. J. Parenter. Enteral. Nutr. 32, 28-35.
27. Heyland, D. K., Dhaliwal, R., Day, A. G., Muscedere, J., Drover, J., Suchner, U., Cook, D., Canadian Critical Care Trials Group (2006) Reducing deaths due to oxidative stress (The REDOXS Study): rationale and study design for a randomized trial of glutamine and antioxidant supplementation in critically-ill patients. Proc. Nutr. Soc. 65, 250-263.
28. Attuwaybi, B., Kozar, R. A., Gates, K. S., Moore-Olufemi, S., Sato, N., Weisbrodt, N. W., Moore, F. A. (2004) Hypertonic saline prevents inflammation, injury, and impaired intestinal transit after gut ischemia/reperfusion by inducing heme-oxygenase-1 enzyme. J. Trauma 56, 749-758.
29. Hassoun, H. T., Kozar, R. A., Kone, B. C., Safi, H. J., Moore, F. A. (2002) Intraischemic hypothermia differentially modulates oxidative stress proteins during mesenteric ischemia/reperfusion. Surgery 132, 369-376.
30. Sato, N., Kozar, R. A., Zou, L., Weatherall, J. M., Attuwaybi, B., Moore-Olufemi, S. D., Weisbrodt, N. W., Moore, F. A. (2005) Peroxisome proliferator-activated receptor õ mediates protection against cyclooxygenase-2-induced gut dysfunction in a rodent model of mesenteric ischemia/reperfusion. Shock 24, 462-469.
31. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812.
32. Sorrentino, S. A., Bahlmann, F. H., Besler, C., Muller, M., Schulz, S., Kirchhoff, N., Doerries, C., Horvath, T., Limbourg, A., Limbourg, F., Fliser, D., Haller, H., Drexler, H., Landmesser, U. (2007) Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone. Circulation 116, 163-173.
33. Hevener, A. L., Olefsky, J. M., Reichart, D., Nguyen, M. T., Bandyopadyhay, G., Leung, H. Y., Watt, M. J., Benner, C., Febbraio, M. A., Nguyen, A. K., Folian, B., Subramaniam, S., Gonzalez, F. J., Glass, C. K., Ricote, M. (2007) Macrophage PPAR γ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. J. Clin. Invest. 117, 1658-1659.
34. Blanquart, C., Barbier, O., Fruchart, J. C., Staels, B., Glineur, C. (2003) Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation. J. Steroid Biochem. Mol. Biol. 85, 267-273.
35. Zingarelli, B., Cook, J. A. (2005) Peroxisome proliferator-activated receptor γ is a new therapeutic target in sepsis and inflammation. Shock 23, 393-399.
36. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., Glass, C. K. (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391, 79-82.
37. Ricote, M., Glass, C. K. (2007) PPARs and molecular mechanisms of transrepression. Biochim. Biophys. Acta 1771, 926-935.
38. Sato, N., Moore, F. A., Marshall, M. A., Zou, L., Moore-Olufemi, S. D., Schultz, S. G., Kozar, R. A. (2005) Immune-enhancing enteral nutrients differentially modulate the early proinflammatory transcription factors mediating gut ischemia/reperfusion. J. Trauma 58, 455-461.
39. Gertzberg, N., Clements, R., Jaspers, I., Ferro, T. J., Neumann, P., Flescher, E., Johnson, A. (2000) Tumor necrosis factor-x-induced activating protein-1 activity is modulated by nitric oxide-mediated protein kinase G activation. Am. J. Respir. Cell Mol. Biol. 22, 105-115.
40. Pascual, G., Fong, A. L., Ogawa, S., Gamliel, A., Li, A. C., Perissi, V., Rose, D. W., Willson, T. M., Rosenfeld, M. G., Glass, C. K. (2005) A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPARγ. Nature 437, 759-763.
41. Al-Rasheed, N. M., Chana, R. S., Baines, J. R., Willars, G. B., Brunskill, N. J. (2004) Ligand-independent activation of peroxisome proliferator-activated receptorγ by insulin and C-peptide in kidney proximal tubular cells. J. Biol. Chem. 279, 49747-49754.
42. Liu, K. D., Glidden, D. V., Eisner, M. D., Parsons, P. E., Ware, L. B., Wheeler, A., Korpak, A., Thompson, B. T., Chertow, G. M., Matthay, M. A., the National Heart, Lung, and Blood Institute ARDS Network Clinical Trials Group (2007) Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Crit. Care Med. 35, 2755-2761.